Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Urinary Bladder Neoplasms × Meropenem × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Bladder Neoplasms 1

Interventions

Gemcitabine 22 Cisplatin 20 Mitomycin 16 BCG Vaccine 10 Paclitaxel 8 Doxorubicin 7 Docetaxel 7 5-aminolevulinic acid hexyl ester 7 pembrolizumab 6 vinflunine 5 apaziquone 5 Vinblastine 5 Radiotherapy 5 Methotrexate 5 Magnetic Resonance Spectroscopy 5 Carboplatin 5 durvalumab 4 atezolizumab 4 Fluorouracil 4 enfortumab vedotin 3 Transurethral Resection of Bladder 3 Surgical Procedures, Operative 3 Specimen Handling 3 Selenium 3 Radiation 3 Nivolumab 3 Filgrastim 3 Cystoscopy 3 Cystectomy 3 valrubicin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05392634 2022-05-31

MACS

N.N. Petrov National Medical Research Center of Oncology

Phase 3 Unknown

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡